Additional studies highlight several critical factors that may contribute to enhanced wound repair with amniotic-derived tissues including extracellular matrix, cytokines and growth factors, stem cells, and immunomodulation of the wound environment.9,10 These studies add to the overall evidence supporting the use of amniotic-derived tissues in regenerative applications by highlighting the importance of processing techniques and how they influence the quality of wound healing
In this review, we reexamine
noteworthy examples where pharmacogenetic testing information was added to drug labelling to explore how the available evidence, potential public health impact, and predictive utility of each pharmacogenetic biomarker impacts clinical uptake.